Paper28678784
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.
Sahin U and 49 others. Nature, 2017. Cited by 1,955 papers, by iCite.
Cite this record
ConductScience Library. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Papers, record 28678784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28678784
- Disease
- melanoma589 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cancer Vaccines | Major topic |
| Melanoma | Major topic |
| Mutation | Major topic |
| Precision Medicine | Major topic |
| RNA | Major topic |
| Antibodies, Monoclonal | |
| B7-H1 Antigen | |
| CD8 Antigens | |
| Epitopes | |
| Humans | |
| Immunotherapy | |
| Neoplasm Metastasis | |
| Neoplasm Recurrence, Local | |
| Nivolumab | |
| Programmed Cell Death 1 Receptor | |
| T-Lymphocytes | |
| Vaccination | |
| beta 2-Microglobulin |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04072900 | A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma | Results | ClinicalTrials.gov | |
| NCT07686744 | Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma | Background | ClinicalTrials.gov |
Comments and corrections5
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 28678783 | Cancer: Precision T-cell therapy targets tumours. | https://conductscience.org/library/papers/28678783 | PubMed |
| Comment in | 28740114 | Tumour vaccines: Personal training by vaccination. | https://conductscience.org/library/papers/28740114 | PubMed |
| Comment in | 28813655 | Making It Personal: Neoantigen Vaccines in Metastatic Melanoma. | https://conductscience.org/library/papers/28813655 | PubMed |
| Comment in | 28867556 | Neoantigen Vaccines Pass the Immunogenicity Test. | https://conductscience.org/library/papers/28867556 | PubMed |
| Comment in | 31538056 | To each his own: a personalized vaccine for metastatic melanoma. | https://conductscience.org/library/papers/31538056 | PubMed |
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26205340 | Evolving synergistic combinations of targeted immunotherapies to combat cancer. | Nat Rev Cancer | 2015 | https://conductscience.org/library/papers/26205340 | PubMed |
| 2 | 22373417 | Optimizing de novo transcriptome assembly from short-read RNA-Seq data: a comparative study. | BMC Bioinformatics | 2011 | https://conductscience.org/library/papers/22373417 | PubMed |
| 3 | 16940422 | Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. | Blood | 2006 | https://conductscience.org/library/papers/16940422 | PubMed |
| 4 | 25901682 | Mutant MHC class II epitopes drive therapeutic immune responses to cancer. | Nature | 2015 | https://conductscience.org/library/papers/25901682 | PubMed |
| 5 | 11932250 | BLAT--the BLAST-like alignment tool. | Genome Res | 2002 | https://conductscience.org/library/papers/11932250 | PubMed |
| 6 | 27959684 | T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27959684 | PubMed |
| 7 | 25428505 | PD-1 blockade induces responses by inhibiting adaptive immune resistance. | Nature | 2014 | https://conductscience.org/library/papers/25428505 | PubMed |
| 8 | 25765070 | Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. | Science | 2015 | https://conductscience.org/library/papers/25765070 | PubMed |
| 9 | 17063328 | Magnetic particles for the separation and purification of nucleic acids. | Appl Microbiol Biotechnol | 2006 | https://conductscience.org/library/papers/17063328 | PubMed |
| 10 | 17379693 | Enhancements and modifications of primer design program Primer3. | Bioinformatics | 2007 | https://conductscience.org/library/papers/17379693 | PubMed |
| 11 | 18516045 | Mapping and quantifying mammalian transcriptomes by RNA-Seq. | Nat Methods | 2008 | https://conductscience.org/library/papers/18516045 | PubMed |
| 12 | 20410931 | Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo. | Gene Ther | 2010 | https://conductscience.org/library/papers/20410931 | PubMed |
| 13 | 27869121 | Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry. | Nat Commun | 2016 | https://conductscience.org/library/papers/27869121 | PubMed |
| 14 | 19934295 | Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19934295 | PubMed |
| 15 | 25837513 | Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. | Science | 2015 | https://conductscience.org/library/papers/25837513 | PubMed |
| 16 | 22517427 | Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. | Brief Bioinform | 2013 | https://conductscience.org/library/papers/22517427 | PubMed |
| 17 | 21045153 | Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity. | Cancer Res | 2010 | https://conductscience.org/library/papers/21045153 | PubMed |
| 18 | 28228285 | Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction. | Immunity | 2017 | https://conductscience.org/library/papers/28228285 | PubMed |
| 19 | 23296927 | Synthetic mRNAs with superior translation and stability properties. | Methods Mol Biol | 2013 | https://conductscience.org/library/papers/23296927 | PubMed |
| 20 | 18503082 | IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. | Nucleic Acids Res | 2008 | https://conductscience.org/library/papers/18503082 | PubMed |
Cited by1,510
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,955 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42936394 | Tumor antigens across cancer progression: from immune recognition and selection to precision cancer immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42936394 | PubMed |
| 42928874 | Nanotechnology-Enabled Immunotherapy for Colorectal Cancer: Overcoming the "Cold" Tumor Microenvironment in Microsatellite-Stable Disease. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42928874 | PubMed |
| 42926996 | Functional Immunopeptidomics by Characterizing Immunopeptides Against HLAs, TCRs, and Antibodies. | Res Sq | 2026 | https://conductscience.org/library/papers/42926996 | PubMed |
| 42920849 | Progress on therapeutic mRNA vaccines for cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42920849 | PubMed |
| 42909179 | Mapping programmable mRNA research relevant to cancer-associated immune escape: a dual-database bibliometric and topic modeling analysis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42909179 | PubMed |
| 42886329 | Cancer nanomedicine and RNA/Lipid nanoparticle platforms in oncology: developmental evolution, translational barriers, and precision-therapy opportunities. | J Egypt Natl Canc Inst | 2026 | https://conductscience.org/library/papers/42886329 | PubMed |
| 42886326 | The haunted Umwelt: a biosemiotic and hauntological account of immune semiotic corruption in field cancerization. | Theory Biosci | 2026 | https://conductscience.org/library/papers/42886326 | PubMed |
| 42871894 | A bottleneck-first evaluation of antigen delivery platforms for therapeutic cancer vaccines. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42871894 | PubMed |
| 42866351 | Exploring the potential of mRNA vaccines in combatting communicable and non-communicable diseases in low-income and lower-middle-income countries. | Ann Med Surg (Lond) | 2026 | https://conductscience.org/library/papers/42866351 | PubMed |
| 42854694 | AI-integrated RNA therapeutics in precision oncology. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42854694 | PubMed |
| 42844249 | Bioengineering strategies for improving the immunogenicity of mRNA vaccines. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42844249 | PubMed |
| 42835554 | Personalized messenger RNA therapy for melanoma and the challenge of global implementation. | JAAD Int | 2026 | https://conductscience.org/library/papers/42835554 | PubMed |
| 42827008 | Self-Assembling Peptide-Adjuvant Conjugate (SaPAC) Platform for Precision Cancer Immunotherapy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42827008 | PubMed |
| 42820749 | Epitope Generation Gateway: A biological context-dependent approach to cancer vaccine development. | Gigascience | 2026 | https://conductscience.org/library/papers/42820749 | PubMed |
| 42798884 | Personalised neoantigen vaccines for precision oncology in Southeast Asia: clinical opportunities, infrastructure challenges, and policy perspectives. | Front Immunol | 2026 | https://conductscience.org/library/papers/42798884 | PubMed |
| 42798731 | AI-driven genotype-phenotype modeling: a framework integrating multi-modal single-cell genomics and reverse vaccinology for de novo design of multi-epitope cancer vaccines. | Front Genet | 2026 | https://conductscience.org/library/papers/42798731 | PubMed |
| 42797572 | From Universal Aspiration to Precision Immunization: A Hypothesis Framework for Antigen-Defined, HLA-Restricted Cancer Vaccines. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42797572 | PubMed |
| 42787418 | Molecular subgroups and biomarker guided precision immunotherapy in triple-negative breast cancer: advances, challenges, and future directions. | Front Immunol | 2026 | https://conductscience.org/library/papers/42787418 | PubMed |
| 42786286 | Localized immunotherapy via dissolving microneedles for the prevention of breast cancer recurrence. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/42786286 | PubMed |
| 42783445 | COVID-19 mRNA Vaccines as Antigen-Agnostic Immunomodulators: A Repurposing Perspective. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42783445 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| B2M | 567 | PubTator's text mining | https://conductscience.org/library/genes/567 | NCBI Gene |
| HLA-G | 3135 | PubTator's text mining | https://conductscience.org/library/genes/3135 | NCBI Gene |
| SPATA2 | 9825 | PubTator's text mining | https://conductscience.org/library/genes/9825 | NCBI Gene |
Drugs3
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| IMIQUIMOD | CHEMBL1282 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1282 | ChEMBL |
| REGRAMOSTIM | CHEMBL2107881 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL2107881 | ChEMBL |
| TORIPALIMAB | CHEMBL4297843 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL4297843 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28678784
GET https://conductscience.org/api/papers/v1/28678784/authors?page=2